Different subtypes of α1A‐adrenoceptor mediating contraction of rat epididymal vas deferens, rat hepatic portal vein and human prostate distinguished by the antagonist RS 17053

1 The α1‐adrenoceptor subtype mediating contraction of the rat hepatic portal vein to phenylephrine was characterized by use of competitive antagonists previously shown to have selectivity between the expressed α1‐subtype clones. Prazosin competitively antagonized the phenylephrine contractions with a pA2 value of 9.2, as did WB 4101 (pA2 9.4), 5‐methyl urapidil (pA2 8.6), indoramin (pA2 8.4) and BMY 7378 (pA2 6.5). 2 The pA2 values on the rat portal vein correlated highly with their previously published pA2 values for the α1A‐adrenoceptors mediating contraction of the rat epididymal vas deferens and human prostate and poorly with those for the α1B‐ and α1D‐adrenoceptors mediating contraction of the rat spleen and aorta, respectively. The antagonist pA2 values on the rat portal vein correlated highly with their previously published pK1 values for the expressed α1a‐clone and poorly with those for the expressed α1b‐ and α1d‐clones. Therefore the results show that contraction of the rat portal vein to phenylephrine is mediated by α1A‐adrenoceptors. 3 The novel α1‐adrenoceptor antagonist RS 17053 had a relatively high affinity for the α1A‐adrenoceptors mediating contraction of the rat epididymal vas deferens (pA2 9.5) compared with the α1B‐adrenoceptors in the rat spleen (pA2 7.2) or the α1D‐adrenoceptors in the rat aorta (pKB 7.1), in agreement with its selectivity for the expressed α1a‐clone. However, RS 17053 had over 100 fold lower affinity for the α1A‐adrenoceptors mediating contraction of the rat portal vein (pKB 7.1) and human prostate (pKB 7.1) compared with its affinity for the α1A‐adrenoceptors in the rat epididymal vas deferens or the expressed α1a‐clone. 4 The difference in affinity of RS 17053 between the rat epididymal vas deferens and rat portal vein cannot be explained by a species difference in the receptor. Therefore RS 17053 may distinguish between subtypes of the α1a‐adrenoceptor in the rat portal vein and human prostate compared with those in the rat epididymal vas deferens or the expressed α1a‐clone.

[1]  R. Graham,et al.  alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling. , 1996, Circulation research.

[2]  T. Stamey,et al.  RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classification. , 1996, Molecular pharmacology.

[3]  I. Marshall,et al.  The role of diacylglycerol and activation of protein kinase C in α1A‐adrenoceptor‐mediated contraction to noradrenaline of rat isolated epididymal vas deferens , 1996, British journal of pharmacology.

[4]  I. Muramatsu,et al.  Two distinct α1‐adrenoceptor subtypes in rabbit liver:a binding study , 1995 .

[5]  C. Chapple,et al.  The role of capacitative Ca2+ influx in the αlB‐adrenoceptor‐mediated contraction to phenylephrine of the rat spleen , 1995, British journal of pharmacology.

[6]  I. Marshall,et al.  Noradrenaline contractions of human prostate mediated by α1c‐(α1c‐) adrenoceptor subtype , 1995 .

[7]  A. Naylor,et al.  Characterization of an α1D‐adrenoceptor mediating the contractile response of rat aorta to noradrenaline , 1995, British journal of pharmacology.

[8]  C. Chapple,et al.  Evidence for a functional α1A‐ (α1C‐) adrenoceptor mediating contraction of the rat epididymal vas deferens and an α1B‐adrenoceptor mediating contraction of the rat spleen , 1995 .

[9]  R. Lefkowitz,et al.  International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. , 1995, Pharmacological reviews.

[10]  G. Tsujimoto,et al.  Cloning, functional expression and tissue distribution of human α 1C‐adrenoceptor splice variants , 1995, FEBS letters.

[11]  A. Goetz,et al.  BMY 7378 is a selective antagonist of the D subtype of α1-adrenoceptors , 1995 .

[12]  C. Teng,et al.  Functional identification of alpha 1-adrenoceptor subtypes in human prostate: comparison with those in rat vas deferens and spleen. , 1994, European journal of pharmacology.

[13]  S. Øie,et al.  Does α1‐Acid Glycoprotein Act as a Non‐functional Receptor for α1‐Adrenergic Antagonists? , 1994 .

[14]  A. Hatano,et al.  Pharmacological evidence of distinct oci‐adrenoceptor subtypes mediating the contraction of human prostatic urethra and peripheral artery , 1994, British journal of pharmacology.

[15]  H. Akino,et al.  Pharmacological characterization of alpha 1-adrenoceptor subtypes in the human prostate: functional and binding studies. , 1994, British journal of urology.

[16]  S. Z. Langer,et al.  Expression of α1-adrenoceptor subtypes in rat tissues : implications for α1-adrenoceptor classification , 1994 .

[17]  A. Ford,et al.  α1-Adrenoceptor classification: sharpening Occam's razor , 1994 .

[18]  P. Molinoff,et al.  International Union of Pharmacology nomenclature of adrenoceptors. , 1994, Pharmacological reviews.

[19]  M. Wyllie,et al.  Pharmacological properties of the cloned α1A/D‐adrenoceptor subtype are consistent with the α1A‐adrenoceptor characterized in rat cerebral cortex and vas deferens , 1994 .

[20]  T. Branchek,et al.  The alpha 1-adrenergic receptor that mediates smooth muscle contraction in human prostate has the pharmacological properties of the cloned human alpha 1c subtype. , 1994, Molecular pharmacology.

[21]  I. Muramatsu,et al.  Two distinct α1-adrenoceptor subtypes in rabbit liver. , 1994 .

[22]  S. Harbon,et al.  Activation of alpha-1A adrenoceptors mobilizes calcium from the intracellular stores in myocytes from rat portal vein. , 1994, The Journal of pharmacology and experimental therapeutics.

[23]  K. Minneman,et al.  Alpha 1-adrenergic receptor subtypes. , 1994, Annual review of pharmacology and toxicology.

[24]  J. Docherty,et al.  Investigation of the subtypes of α1‐adrenoceptor mediating contractions of rat aorta, vas deferens and spleen , 1993, British journal of pharmacology.

[25]  I. Muramatsu,et al.  Identification of α1‐adrenoceptor subtypes in the rat vas deferens: binding and functional studies , 1992 .

[26]  S. Øie,et al.  The Effect of α1‐Acid Glycoprotein on the Pharmacological Activity of α1‐Adrenergic Antagonists in Rabbit Aortic Strips , 1991 .

[27]  I. Muramatsu,et al.  Pharmacological subclassification of α1‐adrenoceptors in vascular smooth muscle , 1990 .

[28]  G. Burnstock,et al.  Characterisation of human prostatic adrenoceptors using pharmacology receptor binding and localisation. , 1989, British journal of urology.

[29]  M. Martí,et al.  Relationship between α-adrenoceptor occupancy and contractile response in rat vas deferens. Experimental and theoretical analysis☆ , 1988 .

[30]  H. Schild,et al.  SOME QUANTITATIVE USES OF DRUG ANTAGONISTS , 1997, British journal of pharmacology and chemotherapy.